New strategy identified to address the underlying cause of LAD1 patients' symptoms

New strategy identified to address the underlying cause of LAD1 patients' symptoms

New strategy identified to address the underlying cause of LAD1 patients' symptoms

Owing to a rare genetic mutation, individuals with leukocyte adhesion deficiency type 1 (LAD1) experience a suite of symptoms that trace back to an immune system dysfunction.